【野村：京东健康2024财年下半年业绩胜预期 升目标价至41.5港元】金十数据3月10日讯，野村发表研报指，京东健康(06618.HK)2024财年下半年收入按年增长13%，分别超出市场及该行预测1%；非国际财务报告准则营运利润率提高0.4个百分点至3.4%，超出该行预测0.2个百分点；非国际财务报告准则净利润按年增长27%，分别超出市场及该行预估15%及6%。野村将京东健康2025及2026财年的收入预测分别上调2%及3%；净利润预测分别下调8%及11%。该行亦维持京东健康的买入评级，将该股的目标价由31港元上调至41.5港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.